C3 and cancer: Of all the complement components that may promote cancer, C1q chains, C5a and C3-derived fragments, which can inhibit antitumor T-cells response via the recruitment and activation of immunosuppressive cell subpopulations like Tregs and M2 TAMs (60), are possibly the most dominant lubricants of tumor progression (61, 62).